Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Protein Biotech Lands $51.5M in First Venture Round

A spin-off enterprise from Harvard developing therapies that block signaling proteins causing disease is raising $51.5 million its first venture funding round. . . . → Read More: Protein Biotech Lands $51.5M in First Venture Round

Radiation Enhances Nanoparticle Cancer Treatments

Targeting tumors with chemotherapy delivered in nanoparticles, preceded with radiation, was shown in lab mice to boost treatments in a range of cancers. . . . → Read More: Radiation Enhances Nanoparticle Cancer Treatments

Moderna, Merck Partner on Personal Cancer Vaccines

Scanning electron micrograph of a human T-cell lymphocyte (National Institute of Allergy and Infectious Diseases, NIH)

29 June 2016. Biotechnology company Moderna Therapeutics and drug maker Merck are developing therapeutic vaccines using messenger RNA that address unique genetic patterns in patients’ tumors. The deal is expected to bring Moderna an immediate payment of $200 . . . → Read More: Moderna, Merck Partner on Personal Cancer Vaccines

More Device Approvals, Higher Risks in Europe than U.S.

(PublicDomainPictures, Pixabay)

29 June 2016. An analysis of regulatory approvals and outcomes shows medical devices are reviewed and approved faster in Europe than the U.S., but also face more safety issues later on. A team from Kings College London and Harvard University published its findings yesterday in the journal BMJ.

Researchers led by Aaron . . . → Read More: More Device Approvals, Higher Risks in Europe than U.S.

Animal-Free Leather Company Gains $40M in Venture Funds

A company making leather for consumer goods with tissue engineering and gene-editing from living cells is raising $40 million in its second venture round. . . . → Read More: Animal-Free Leather Company Gains $40M in Venture Funds

3-D Printing Technique Devised for Replacement Cartilage

Biomedical engineers developed a process for directly printing replacement cartilage without the scaffolds needed in previous tissue engineering techniques. . . . → Read More: 3-D Printing Technique Devised for Replacement Cartilage

Partnership Advising Women on C-Section Options

An academic-business initiative is providing pregnant women with more information on birth options, particularly Cesarean section surgery. . . . → Read More: Partnership Advising Women on C-Section Options

Grant for Research on Drugs to Improve Tissue Transplants

(skeeze, Pixabay)

27 June 2016. Department of Defense is funding research on new drugs that aim to improve the quality of tissue and limbs for transplants donated from people whose brains stop working. DoD awarded the grant of nearly $1 million to the Institute for Transformative Molecular Medicine at Case Western Reserve University School . . . → Read More: Grant for Research on Drugs to Improve Tissue Transplants

Genome Editing Company Adds $38M in Venture Funds

Crispr Therapeutics, a company creating treatments for disease that edit the human genome, is raising another $38 million in its second venture financing round. . . . → Read More: Genome Editing Company Adds $38M in Venture Funds

Start-Up Developing Nanomedicines for Transplants

A spin-off enterprise from Medical University of South Carolina is creating drug delivery techniques that make it safer for patients needing organ transplants. . . . → Read More: Start-Up Developing Nanomedicines for Transplants